Similar to This
Previous
Therapy for pancreatic cancer awaits EU approval: A new drug extends the lives of people with advanced pancreatic cancer. The EMA is now recommending its ...
spektrum.de/news/daraxonrasib-gegen-bauchspeicheldruesenkrebs-vor-eu-zuslassung/2350015

EU medicines agency recommends approval of new pancreatic cancer drug: The European Medicines Agency (EMA) has recommended the approval of a new drug to treat ...
app.ekkow.com/1483480985377505830

Revolutionary cancer drug soon available in Europe: Daraxonrabis, a new drug against pancreatic cancer, has received the green light from the European Medicines ...
sueddeutsche.de/gesundheit/bauchspeicheldruesenkrebs-daraxonrasib-krebsmedikament-ema-europa-li.3564057

Lung cancer: Drug approved by FDA for pancreatic cancer may help: Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer ...
medicalnewstoday.com/articles/pancreatic-cancer-drug-may-also-help-fight-treatment-resistant-lung-cancer
Landmark pancreatic cancer drug shows potential against lung cancer too: Results bolster hopes that the drug daraxonrasib could prove effective against a variety ...
nature.com/articles/d41586-026-02745-5

South Florida patients see early promising results from new pancreatic cancer pill
miamiherald.com/news/health-care/article317090588.html

FDA approves 'life-altering' pancreatic cancer drug that nearly doubles life expectancy
nypost.com/2026/08/26/health/fda-approves-pancreatic-cancer-drug-that-nearly-doubles-life-expectancy/

FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives: In trials, Revolution Medicines’ daraxonrasib nearly doubled average survival times ...
washingtonpost.com/health/2026/08/26/fda-approves-landmark-pancreatic-cancer-drug-daraxonrasib/
More time for metastatic pancreatic cancer patients : An experimental drug appears to be extending the lives of patients already in the advanced stages of the ...
thestar.com.my/lifestyle/health/2026/08/22/more-time-for-metastatic-pancreatic-cancer-patients

Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
chicagotribune.com/2026/08/09/daraxonrasib-pancreatic-cancer-drug/

Revolution Medicines: After pancreatic cancer breakthrough - | will everything happen very quickly now?
deraktionaer.de/artikel/pharma-biotech/revolution-medicines-nach-bauchspeicheldruesenkrebs-durchbruch-geht-jetzt-alles-ganz-schnell-20404295.html

A New Medication May Double the Survival Time for Pancreatic Cancer Patients: Oncologists break down what you need to know about daraxonrasib, an experimental ...
womenshealthmag.com/health/a71561112/daraxonrasib-pancreatic-cancer-study/

US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
reuters.com/legal/litigation/us-cancer-clinics-scramble-get-experimental-revolution-medicines-pancreatic-2026-05-14/

Promising pancreatic cancer drug has high rate of mostly manageable side effects
monitor.co.ug/uganda/magazines/healthy-living/promising-pancreatic-cancer-drug-has-high-rate-of-mostly-manageable-side-effects--5449906

FDA expands access to pancreatic cancer drug helping patients like Ben Sasse: Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing ...
cbsnews.com/news/daraxonrasib-pancreatic-cancer-drug-fda-expanded-access-ben-sasse/

Jarvis: Finally, real progress against pancreatic cancer: 'The drug has already taught the field that powerfully suppressing this key (disease) driver ...
mercurynews.com/2026/04/23/jarvis-finally-real-progress-against-pancreatic-cancer/

Two New Drugs Offer Hope for Pancreatic Cancer: New experimental medications seem to extend survival with the hard-to-treat cancer.
time.com/article/2026/04/14/new-promise-for-treating-pancreatic-cancer/

Revolution Medicines' experimental cancer pill boosts survival in late-stage study
reuters.com/business/healthcare-pharmaceuticals/revolution-medicines-experimental-cancer-pill-helps-improve-survival-late-stage-2026-04-13/

"Every year is a bonus" - | New drug offers hope for pancreatic cancer: "What do I have to lose?" With this attitude, Debby Orcutt participated in a study ...
giessener-anzeiger.de/panorama/jedes-jahr-ist-ein-bonus-neues-medikament-gibt-hoffnung-bei-bauchspeicheldruesenkrebs-zr-94051300.html

Next